HitTheBid sorry to hear about your earlier losses,
Like yourself I have been fully aware of the history before coming a shareholder of TRU. the company new company has since been refreshed The new upgraded device is now more accurate, The board and management has been refreshed The company has had many more clinical trials conducted by Hospitals showing results that are at least equal to or better than the pap test. The cost per test ( according to my research ) is significantly more competitive thn PAP test The company has sold many more devises than the old company ( with many more future orders in place) I think that overtime it will be apparent that like Pacific Edge CX bladder test the Truscreen test will prove ( overtime) to be a disruptive technology
The emphasis here being overtime but we will see that with this technology the patient investor (IMHO) with this stock will be greatly rewarded
also The Chaiman ( who has been actively involved in the Chinese marketing and was running the company on a daily basis during the CEO change over ) has been yet again been buying on market.
TRU Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
